TipRanks
Advertisement
Advertisement

PFE Stock Latest News

Pfizer Shuts One Trial, Bets Big on New Vaccine
Weekend UpdatesPfizer Shuts One Trial, Bets Big on New Vaccine
24h ago
PFE
Pfizer Halts Mid-Stage ITP Trial: What Termination of PF-06835375 Means for PFE Investors
PremiumCompany Announcements
Pfizer Halts Mid-Stage ITP Trial: What Termination of PF-06835375 Means for PFE Investors
2d ago
PFE
Pfizer’s Next‑Gen Pneumococcal Shot Enters Key Phase 3 Test, Extending Vaccine Growth Potential
PremiumCompany Announcements
Pfizer’s Next‑Gen Pneumococcal Shot Enters Key Phase 3 Test, Extending Vaccine Growth Potential
4d ago
PFE
Pfizer (PFE) Ramps Up Three Phase 3 Trials, Tempting Bulls
PremiumWeekend Updates
Pfizer (PFE) Ramps Up Three Phase 3 Trials, Tempting Bulls
8d ago
PFE
NIH makes big bet on public-private partnership over cancer vaccines, NYT says
PremiumThe Fly
NIH makes big bet on public-private partnership over cancer vaccines, NYT says
9d ago
AZN
JNJ
Pfizer’s New RSV Vaccine Trial Targets Older Adults, Signaling Long-Term Growth Potential
PremiumCompany AnnouncementsPfizer’s New RSV Vaccine Trial Targets Older Adults, Signaling Long-Term Growth Potential
9d ago
PFE
Pfizer’s New Asthma Bet: Tilrekimig Phase 3 Trial Moves Forward
Premium
Company Announcements
Pfizer’s New Asthma Bet: Tilrekimig Phase 3 Trial Moves Forward
9d ago
PFE
Pfizer price target raised to $30 from $28 at JPMorgan
Premium
The Fly
Pfizer price target raised to $30 from $28 at JPMorgan
9d ago
PFE
Pfizer price target raised to $29 from $27 at BofA
PremiumThe Fly
Pfizer price target raised to $29 from $27 at BofA
9d ago
PFE
Pfizer’s VESPER-OSA 1 Trial Targets Sleep Apnea and Obesity With Monthly Shot
PremiumCompany Announcements
Pfizer’s VESPER-OSA 1 Trial Targets Sleep Apnea and Obesity With Monthly Shot
10d ago
PFE
Cboe data shows mixed options sentiment in Pfizer with shares down 1.38%
PremiumThe Fly
Cboe data shows mixed options sentiment in Pfizer with shares down 1.38%
10d ago
PFE
Pfizer price target raised to $28 from $27 at Cantor Fitzgerald
PremiumThe Fly
Pfizer price target raised to $28 from $27 at Cantor Fitzgerald
10d ago
PFE
Pfizer to cut 300 jobs in Italy, confirms closure of penicillins department
PremiumThe FlyPfizer to cut 300 jobs in Italy, confirms closure of penicillins department
10d ago
PFE
Pfizer announces FDA approval of TUKYSA regimen for HER2+ breast cancer
Premium
The Fly
Pfizer announces FDA approval of TUKYSA regimen for HER2+ breast cancer
11d ago
PFE
Pfizer price target raised to $33 from $30 at Scotiabank
Premium
The Fly
Pfizer price target raised to $33 from $30 at Scotiabank
11d ago
PFE
Pfizer price target raised to $33 from $30 at Scotiabank
PremiumThe Fly
Pfizer price target raised to $33 from $30 at Scotiabank
12d ago
PFE
Moderately bullish activity in Pfizer with shares up 0.24%
PremiumThe Fly
Moderately bullish activity in Pfizer with shares up 0.24%
12d ago
PFE
Becton Dickinson (BDX) Joins Trump Tariff Exemption Scramble with $19B Investment Plan
PremiumMarket News
Becton Dickinson (BDX) Joins Trump Tariff Exemption Scramble with $19B Investment Plan
12d ago
AZN
BDX
Biotech TRex Bio Set to Roar Onto Nasdaq With $133M IPO
PremiumMarket News
Biotech TRex Bio Set to Roar Onto Nasdaq With $133M IPO
13d ago
JNJ
LLY
Pfizer (PFE) Quietly Builds New Cancer And RSV Powerhouse
PremiumWeekend UpdatesPfizer (PFE) Quietly Builds New Cancer And RSV Powerhouse
15d ago
PFE
Pfizer’s TACTIVE-U Breast Cancer Combo Trial Reaches Key Milestone
Premium
Company Announcements
Pfizer’s TACTIVE-U Breast Cancer Combo Trial Reaches Key Milestone
16d ago
PFE
Pfizer says LITFULO significantly improved repigmentation in patients
Premium
The Fly
Pfizer says LITFULO significantly improved repigmentation in patients
16d ago
PFE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >